News tagged with metastasize
KRAS and BRAF mutation screening in metastatic colorectal cancer costly in relation to benefits
Researchers report that screening for KRAS and BRAF mutations can reduce the cost of anti-EGFR treatment for metastatic colorectal cancer but with a very small reduction in overall survival according to a new study published ...
Cancer
Nov 28, 2012 |
not rated yet |
0
Study shows bone metastases treatment can improve overall survival
It is common for patients initially diagnosed with lung cancer to have the cancer spread to sites like the liver, brain and bone. One of the most frequent sites of metastases is the bone, with an estimated 30 to 40 percent ...
Cancer
Nov 15, 2012 |
not rated yet |
0
Targeting protein could prevent metastasis of cancer cells
(Medical Xpress)—Researchers at King's College London have uncovered a protein required by cancer cells to spread to other parts of the body, highlighting it as a potential target for future treatments ...
Cancer
Nov 14, 2012 |
5 / 5 (1) |
0
|
Vandetanib in thyroid cancer: No proof of added benefit
Vandetanib (trade name Caprelsa) has been approved in Germany since February 2012 for adult patients suffering from a particular form of aggressive thyroid cancer. The German Institute for Quality and Efficiency in Health ...
Cancer
Nov 09, 2012 |
not rated yet |
0
Considerable added benefit of ipilimumab in advanced melanoma
The humanized antibody ipilimumab (trade name Yervoy) has been approved since August 2011 for the treatment of adult patients with advanced melanoma (black skin cancer) who have already been treated. The term "advanced" means ...
Cancer
Nov 09, 2012 |
not rated yet |
0
Drug combination shrinks secondary brain tumours in breast cancer without substantial side effects of radiotherapy
The sizeable and increasing proportion of women with advanced breast cancer whose disease has spread to the brain could be effectively treated systemically with a combination of two drugs, sparing them the debilitating neurological ...
Cancer
Nov 01, 2012 |
5 / 5 (1) |
0
Combination treatment may improve survival of breast cancer patients with brain metastases
Adding an angiogenesis inhibitor to treatment with a HER2-inhibiting drug could improve outcomes for patients with HER2-positive breast cancer who develop brain metastases. In their report published online in PNAS Plus, ...
Cancer
Nov 01, 2012 |
not rated yet |
0
Hunting for the last remaining tumour cell
The 7.5 millilitres of blood contained in a standard sample tube is not nearly enough to detect circulating tumour cells (CTCs) in the blood of patients with metastatic breast cancer, prostate cancer, or ...
Cancer
Oct 29, 2012 |
not rated yet |
0
Gene signature validated for oral cancer metastases
(HealthDay)—A multigene signature effectively predicts the presence of lymph node metastases in squamous cell carcinoma of the oral cavity (OSCC) and oropharynx (OPSCC), according to a study published online ...
Cancer
Oct 14, 2012 |
not rated yet |
0
Prostate cancer: Curcumin curbs metastases
Powdered turmeric has been used for centuries to treat osteoarthritis and other illnesses. Its active ingredient, curcumin, inhibits inflammatory reactions. A new study led by a research team at Ludwig-Maximilians-Universität ...
Cancer
Oct 12, 2012 |
5 / 5 (2) |
0
|
New animal models can revolutionize the study of cancer
Some animal models developed by researchers at the Institute of Biomedical Research of Bellvitge (IDIBELL) and the Catalan Institute of Oncology (ICO) has served to validate the effectiveness of a new drug ...
Cancer
Oct 09, 2012 |
not rated yet |
0
Endotrophin links obesity to breast cancer progression
Fat cells (adipocytes) surround breast tumors and contribute to tumor growth by expressing factors that aid oncogenesis. Col6 is a protein that is highly expressed in adipocytes and its expression is further increased in ...
Cancer
Oct 08, 2012 |
not rated yet |
0
New drug shrinks brain tumours in melanoma patients
(Medical Xpress)—Australian researchers have given hope to patients with advanced melanoma by showing that a new drug targeting a common mutation in melanoma successfully shrank tumours that had spread to the brain.
Cancer
Oct 08, 2012 |
not rated yet |
0
|
Potential new colorectal cancer treatment target identified
(HealthDay)—The cell surface marker carcinoembryonic antigen-related cell adhesion molecule 6 (CD66c) is a novel marker for colorectal cancer stem cell isolation, which halts tumor growth when silenced, ...
Cancer
Oct 07, 2012 |
not rated yet |
0
First study of clonal evolution in Maxillary Sinus Carcinoma
Knowing how tumors evolve can lead to new treatments that could help prevent cancer from recurring, according to a study published today by the Translational Genomics Research Institute (TGen) and Scottsdale Healthcare.
Cancer
Sep 28, 2012 |
not rated yet |
0
